Thrivent Financial for Lutherans Lowers Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Thrivent Financial for Lutherans trimmed its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 56,632 shares of the company’s stock after selling 2,520 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.11% of Prestige Consumer Healthcare worth $4,083,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Lombard Odier Asset Management USA Corp bought a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at approximately $550,000. CANADA LIFE ASSURANCE Co grew its position in shares of Prestige Consumer Healthcare by 19.4% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock worth $3,453,000 after buying an additional 7,715 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 12.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after acquiring an additional 1,120 shares in the last quarter. Atria Investments Inc purchased a new position in Prestige Consumer Healthcare during the 1st quarter valued at about $1,246,000. Finally, Public Employees Retirement System of Ohio lifted its position in Prestige Consumer Healthcare by 20.5% during the 1st quarter. Public Employees Retirement System of Ohio now owns 80,950 shares of the company’s stock valued at $5,874,000 after acquiring an additional 13,760 shares during the period. Institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. DA Davidson reaffirmed a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus target price of $83.67.

Insider Activity at Prestige Consumer Healthcare

In other news, CEO Ronald M. Lombardi sold 10,875 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares of the company’s stock, valued at $26,510,635.20. This trade represents a 3.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider William P’pool sold 8,987 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total transaction of $735,585.95. Following the completion of the sale, the insider now owns 20,058 shares of the company’s stock, valued at $1,641,747.30. This represents a 30.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 38,810 shares of company stock valued at $3,187,300 over the last ninety days. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Stock Up 0.8 %

NYSE:PBH opened at $84.85 on Monday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. The firm has a market cap of $4.19 billion, a P/E ratio of 20.64, a P/E/G ratio of 2.37 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $85.22. The firm has a 50-day simple moving average of $74.34 and a two-hundred day simple moving average of $70.68.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. During the same quarter last year, the firm earned $1.07 earnings per share. The firm’s quarterly revenue was down .9% compared to the same quarter last year. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.